Investments in cutting-edge tooling and test center drive growth for global healthcare innovators
GERMANTOWN, Wisc. (April 25, 2024) – MGS, a global leader in healthcare end-to-end engineering and manufacturing solutions, is proud to announce the completion of significant upgrades to its Lynge, Denmark engineering facility to complete its transformation into a state-of-the-art tooling facility. The two-phased upgrades of the MGS Lynge facility, previously Winther Mould Technology A/S, began shortly following the company’s acquisition in 2023.
Transforming the Lynge facility from a traditional moldmaker into a best-in-class European toolmaker involved strategic investments in processes, equipment and technology advancements in accordance with MGS’ global tooling standards. This state-of-the-art campus features 4,000 square meters of production space dedicated to early supplier involvement (ESI), design for manufacturability (DFM), Fast-Track pilot tooling, production tool development and enhanced metrology systems.
At MGS Lynge, teams now have access to expanded machining capabilities with 5-axis laser texturing and high-speed milling as well as automated robotic handling. With the facility upgrades, the Lynge team will be able to accelerate production while maximizing capacity and ensuring exceptional quality, which is essential for the company’s Pharma, Diagnostics and MedTech customers.
MGS President and CEO Paul Manley stated, “Through strategic acquisitions of companies like Winther Mould Technology, we are building capacity to bring advanced technologies to global innovators who require precision tooling for critical innovations that improve lives. The upgrades to this facility allow us to enhance the team’s existing capabilities and expertise while standardizing processes to facilitate collaboration across our global engineering teams.”
The second phase of the facility upgrades will bring updates to the 3,000-square-meter Innovation and Test Center that houses first off tool (FOT), design of experiment (DOE), validation, transfer and pilot production. Customers will be able to access plug-and-play space for validation with injection molding machines ranging from 50-300 metric tons. Work is expected to start on phase two in May and be completed in October.
“Building on Winther Mould’s rich history as a premier healthcare tooling manufacturer while transforming into a state-of-the-art facility has been an exciting endeavor,” said Ken Hansen, production director at MGS Lynge. We are proud to be part of MGS’ continued efforts to be a world-class healthcare manufacturer from upfront product design and development through final production.”
To learn more about MGS Lynge, visit our website.
About MGS
Headquartered in Germantown, Wisconsin, USA, MGS is a leading end-to-end solutions provider bridging the gap between imagination and realization for healthcare innovators. For leading Pharmaceutical, Diagnostic and MedTech companies, MGS provides the right balance to drive vital innovations: robust, vertically integrated global capabilities – from design to full assembly – combined with the strong customer focus and seamless collaboration of an agile partner. Customers can access these capabilities from any of the company’s 12 global locations. Learn more at www.mgsmfg.com.